scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11883-000-0068-2 |
P698 | PubMed publication ID | 11122763 |
P2093 | author name string | Muhlestein JB | |
P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
Association between dental health and acute myocardial infarction | Q24675367 | ||
The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. | Q37060579 | ||
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study | Q37875542 | ||
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 | ||
Animal models for Chlamydia pneumoniae infection | Q37879491 | ||
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction | Q37882562 | ||
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
Association of chlamydial infection with cerebrovascular disease | Q37884018 | ||
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland | Q37885075 | ||
Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease | Q37887196 | ||
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain | Q37890285 | ||
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques | Q37892518 | ||
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. | Q37896793 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina | Q39817564 | ||
Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 | ||
New insights into the pathogenesis and prevention of acute coronary syndromes | Q41531482 | ||
Chlamydia pneumoniae and acute arterial thrombotic disease | Q43432114 | ||
Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. | Q52306854 | ||
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment | Q73071011 | ||
Anti-inflammatory activity of macrolides: a new therapeutic potential? | Q74525799 | ||
P433 | issue | 4 | |
P921 | main subject | coronary artery disease | Q844935 |
P304 | page(s) | 336-341 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
P1476 | title | Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events | |
P478 | volume | 2 |
Search more.